EP3266456
COMBINATIONS OF LIPOSOMAL IRINOTECAN, 5-FU AND LEUCOVORIN FOR THE TREATMENT OF PANCREATIC CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.6.2013EP published:
5.5.2021EP application number:
17169098.5
EPO information:
European Patent Register
Max expiry date:
11.6.2033
Title:
COMBINATIONS OF LIPOSOMAL IRINOTECAN, 5-FU AND LEUCOVORIN FOR THE TREATMENT OF PANCREATIC CANCER
Timeline
Today
12.6.2013EP application
5.5.2021EP Publication
Owner
Name:
Ipsen Biopharm Ltd.Address:
Ash Road, Wrexham Industrial Estate Wrexham LL13 9UF, GB
Inventor
Name:
BAYEVER, ElielAddress:
New York, NY 10023, US
Name:
DHINDSA, NavreetAddress:
Boston, MA 02127, US
Name:
FITZGERALD, Jonathan, BasilAddress:
Arlington, MA 02474, US
Name:
LAIVINS, PeterAddress:
Scituate, MA 02066, US
Name:
MOYO, VictorAddress:
Ringoes, NJ 08551, US
Name:
NIYIKIZA, CletAddress:
Gulph Mills, PA 19428, US
Name:
KIM, JaeyeonAddress:
Lexington, MA 02420, US
Priority
Number:
201261659211 PDate:
13.6.2012Country:
US
Number:
201361784382 PDate:
14.3.2013Country:
US
Classification
Categories:
A61K 31/4745, A61K 31/513, A61K 31/519, A61K 45/06, A61P 35/00, A61K 9/00, A61K 9/127, A61P 1/18, A61P 9/00, A61P 43/00